Hamilton Medical Center- Hospice Medicare Approved Location: 1275 Elkwood Drive, Dalton, Georgia 30720 Phone: (706) 278-2848 |
Amedisys Hospice Of Dalton Medicare Approved Location: 1510 North Thornton Avenue, Suite 200, Dalton, Georgia 30720 Phone: (706) 259-2518 |
Heartlite Hospice Medicare Approved Location: 1008 Professional Blvd Suite 4, Dalton, Georgia 30720 Phone: (706) 272-1035 |
Homestead Hospice Of Northwest Georgia, Llc Medicare Approved Location: 1514 W Walnut Avenue, Dalton, Georgia 30721 Phone: (706) 217-1926 |
News Archive
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its PLacental eXpanded (PLX)-PAD cells for the treatment of intermittent claudication (IC), a peripheral artery disease (PAD). The double blind, randomized, placebo controlled trial enrolled 50 patients since October 2015 in the U.S., Germany, Israel, and South Korea.
The most common heart medications may get an assist from nitric oxide circulating in the body, according to a new study out of Case Western Reserve University School of Medicine.
The results from a very well-done meta-analysis support other data generated on the risk of alcohol consumption and gastric cancer - that is - that the risk may be real for heavy alcohol consumption but not for moderate intake.
Amadeus Consulting, a custom software development company, recently developed iBirth for Android a mobile application for Lula B, LLC. Created by two mothers in Boulder, Colorado, Lula B wanted an app to help women through the childbirth process to ensure they have the information available for a safe, healthy, and empowering pregnancy.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Voriconazole Tablets, 50 mg and 200 mg, under a previously announced settlement and license agreement with Pfizer Inc. Mylan was the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for Voriconazole Tablets and was awarded 180 days of marketing exclusivity.
› Verified 7 days ago